We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA's Accelerated Approval Process Flawed, Contends Markey
FDA's Accelerated Approval Process Flawed, Contends Markey
June 3, 2005
The FDA’s accelerated approval process for drugs is “broken,” contends a top Democratic representative, who says a review of agency data reveals drug companies aren’t completing the postmarketing studies they promised to perform after gaining approval of their products.